Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Tax Withholding of 2,528 TRDA shares, $18.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 2,528 | $18.1K |
| May 4, 2026 | Entrada Therapeutics, Inc. (TRDA) | Exercise/Conversion | 15,000 | $26.1K |
| Mar 11, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 3,116 | $40.6K |
| Mar 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 55,800 | n/a |
| Sep 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 1,746 | $9.5K |
| Mar 4, 2025 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 60,800 | n/a |
| Sep 30, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 847 | $13.6K |
| Sep 10, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 399 | $6.1K |
| Sep 5, 2024 | Entrada Therapeutics, Inc. (TRDA) | Tax Withholding | 483 | $7.6K |
| Aug 20, 2024 | Entrada Therapeutics, Inc. (TRDA) | Exercise/Conversion | 20,000 | $34.8K |